Gilead Sciences (GILD)
$68.10 0.41 (0.60%)
18:18 EDT GILD Stock Quote Delayed 30 Minutes
Previous Close $68.51
Market Cap 88.55B
PE Ratio 25.89
Volume (Avg. Vol.) 10.20M
Day's Range 67.92 - 69.18
52-Week Range 60.89 - 85.97
Dividend & Yield 2.23 (3.27%)
GILD Stock Predictions, Articles, and Gilead Sciences News
- From InvestorPlace
- From the Web
As the pandemic continues to grow, these four coronavirus stocks are great ways to protect your portfolio for the foreseeable future.
Earnings season is upon us, and Johnson & Johnson (NYSE:JNJ) will kick off second-quarter reporting for the big pharmaceutical stocks on July 16.
As pharmaceutical companies rush to manufacture coronavirus vaccine and drugs, it makes sense to hold some potential winners.
A handful of pharmaceutical stocks have been on fire these days, but I'm writing for a "buy" prescription for five of the best names now.
With pandemic fears shuttering many economies, most investments have cratered. However, a small group of coronavirus stocks may offer significant upside potential.
By Thomas Niel
Consider these seven cash stocks (both defensive and cyclical) as strong buys with upside relative to risk, as markets continue to yo-yo.
Signs continue to mount that remdesivir is a highly effective treatment for the coronavirus. The drug will move the needle for GILD stock.
Gilead is moving into commercial production of Remdesivir, a COVID-19 treatment with an aggressive pricing model, but other biotech solutions could come out ahead; it's early days still.
GILD stock has been rallying, but it has been running out of momentum lately. Just don't lose focus on the positives for Gilead.
Nvidia caught a huge price target increase, while Apple looks to reopen its stores. Here's what happened in the stock market today.
Positive signs continue to mount for remdesivir, yet the market continues to have mixed feelings about GILD stock.
With remdesivir poised to become a blockbuster drug for Gilead, GILD stock still looks poised to prove the bears wrong
Under any other circumstance, sell in May and go away may be considered a sound strategy. In this crisis, though, you may want to keep these stocks to buy for the long haul.
Could the S&P 500 be heading for 3,000? Plus, Chesapeake Energy is on the brink. Here's what else happened in the stock market today.
Gilead Sciences is donating 1.5 million doses of remdesivir, which has many analysts bullish on GILD stock now.
With some countries and states moving to reopen businesses, Capital One Financial Corporation (NYSE:COF) is an excellent target for a bullish put write.
Thursday's big stock charts feature names that moved sharply on red-hot news stories
The remdesivir news took precedent over headlines about first-quarter GDP, which contracted 4.8%, or the worst shrinkage experienced by the world's largest economy since the dark days of the global financial crisis.
Google's earnings boosted the Nasdaq, while small-cap stocks continue to roar to life. Here's what happened in the stock market today.
Navellier RatingsPowered by Portfolio Grader